Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Vlaeminck

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Seminars in Cancer Biology|August 13, 2021
Exosomes and prostate cancer managementV Vlaeminck-Guillem
Annales D'Endocrinologie|January 1, 1997
[Pre-toxic adrenocortical adenoma ("pre-Cushing syndrome"): role of 17-hydroxyprogesterone dosage under ACTH analog stimulation. Apropos of a case]V Vlaeminck, D Dewailly
Annales D'Endocrinologie|November 21, 2000
[Physiology and pathophysiology of thyroid hormone receptors: the contributions of murine models]V Vlaeminck-Guillem, J L Wemeau
Presse Medicale (Paris, France : 1983)|October 16, 1999
[Pseudohypoparathyroidism and the concept of hormonal resistance. Diagnosis, classification and therapy]V Vlaeminck-Guillem, J L Wémeau
Presse Medicale (Paris, France : 1983)|October 16, 1999
[Pseudohypoparathyroidism and the concept of hormonal resistance. Types Ib and II]V Vlaeminck-Guillem, J L Wémeau
Presse Medicale (Paris, France : 1983)|October 16, 1999
[Pseudohypoparathyroidism and the concept of hormonal resistance. Types Ia and Ic and pseudohypoparathyroidism]V Vlaeminck-Guillem, J L Wémeau
La Revue De Medecine Interne|January 15, 2000
[Thyroid hormone resistance syndromes: clinical aspects]V Vlaeminck-Guillem, J L Wémeau
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 10, 2008
[Value of urinary PCA3 test for prostate cancer diagnosis]V Vlaeminck-Guillem, A Ruffion, J Andre
Annales D'Endocrinologie|July 13, 2000
[Suppressive hormone therapy for thyroid nodules. Prospective evaluation. Preliminary results]J L Wémeau, C Cousty, V Vlaeminck
Annales D'Endocrinologie|April 23, 2003
Activating mutations of TSH receptorP Rodien, S-C Ho, V Vlaeminck, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Seminars in Cancer Biology|August 13, 2021
Exosomes and prostate cancer managementV Vlaeminck-Guillem
Annales D'Endocrinologie|January 1, 1997
[Pre-toxic adrenocortical adenoma ("pre-Cushing syndrome"): role of 17-hydroxyprogesterone dosage under ACTH analog stimulation. Apropos of a case]V Vlaeminck, D Dewailly
Annales D'Endocrinologie|November 21, 2000
[Physiology and pathophysiology of thyroid hormone receptors: the contributions of murine models]V Vlaeminck-Guillem, J L Wemeau
Presse Medicale (Paris, France : 1983)|October 16, 1999
[Pseudohypoparathyroidism and the concept of hormonal resistance. Diagnosis, classification and therapy]V Vlaeminck-Guillem, J L Wémeau
Presse Medicale (Paris, France : 1983)|October 16, 1999
[Pseudohypoparathyroidism and the concept of hormonal resistance. Types Ib and II]V Vlaeminck-Guillem, J L Wémeau
Presse Medicale (Paris, France : 1983)|October 16, 1999
[Pseudohypoparathyroidism and the concept of hormonal resistance. Types Ia and Ic and pseudohypoparathyroidism]V Vlaeminck-Guillem, J L Wémeau
La Revue De Medecine Interne|January 15, 2000
[Thyroid hormone resistance syndromes: clinical aspects]V Vlaeminck-Guillem, J L Wémeau
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 10, 2008
[Value of urinary PCA3 test for prostate cancer diagnosis]V Vlaeminck-Guillem, A Ruffion, J Andre
Annales D'Endocrinologie|July 13, 2000
[Suppressive hormone therapy for thyroid nodules. Prospective evaluation. Preliminary results]J L Wémeau, C Cousty, V Vlaeminck
Annales D'Endocrinologie|April 23, 2003
Activating mutations of TSH receptorP Rodien, S-C Ho, V Vlaeminck, et al.
Pageof 3